We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
226 hedge funds and large institutions have $4.62B invested in Madrigal Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 91 increasing their positions, 58 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more funds holding in top 10
Funds holding in top 10: 6 → 14 (+8)
88% more call options, than puts
Call options by funds: $310M | Put options by funds: $165M
82% more capital invested
Capital invested by funds: $2.54B → $4.62B (+$2.08B)
75% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 32
57% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 58
10% more funds holding
Funds holding: 205 → 226 (+21)
6.9% more ownership
Funds ownership: 94.02% → 100.92% (+6.9%)
Holders
226
Holders Change
+21
Holders Change %
+10.24%
% of All Funds
3.29%
Holding in Top 10
14
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+133.33%
% of All Funds
0.2%
New
56
Increased
91
Reduced
58
Closed
32
Calls
$310M
Puts
$165M
Net Calls
+$145M
Net Calls Change
+$31.1M
Top Buyers
| 1 |
PC
Paulson & Co
New York
|
+$106M |
| 2 |
RI
RTW Investments
New York
|
+$88.5M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$74.3M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$58.4M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$56.8M |
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$63.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$46.6M |
| 3 |
O
OrbiMed
New York
|
-$37M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$25.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$24.6M |
